GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » HeartSciences Inc (NAS:HSCS) » Definitions » Equity-to-Asset

HSCS (HeartSciences) Equity-to-Asset : 0.31 (As of Jan. 2025)


View and export this data going back to 2022. Start your Free Trial

What is HeartSciences Equity-to-Asset?

Equity to Asset ratio is calculated as total stockholders equity divided by total asset. HeartSciences's Total Stockholders Equity for the quarter that ended in Jan. 2025 was $1.79 Mil. HeartSciences's Total Assets for the quarter that ended in Jan. 2025 was $5.70 Mil.

The historical rank and industry rank for HeartSciences's Equity-to-Asset or its related term are showing as below:

HSCS' s Equity-to-Asset Range Over the Past 10 Years
Min: -2.9   Med: 0.16   Max: 0.8
Current: 0.31

During the past 5 years, the highest Equity to Asset Ratio of HeartSciences was 0.80. The lowest was -2.90. And the median was 0.16.

HSCS's Equity-to-Asset is ranked worse than
82.4% of 875 companies
in the Medical Devices & Instruments industry
Industry Median: 0.64 vs HSCS: 0.31

HeartSciences Equity-to-Asset Historical Data

The historical data trend for HeartSciences's Equity-to-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HeartSciences Equity-to-Asset Chart

HeartSciences Annual Data
Trend Apr20 Apr21 Apr22 Apr23 Apr24
Equity-to-Asset
0.16 -0.99 -2.90 0.07 0.77

HeartSciences Quarterly Data
Apr20 Apr21 Jul21 Oct21 Jan22 Apr22 Jul22 Oct22 Jan23 Apr23 Jul23 Oct23 Jan24 Apr24 Jul24 Oct24 Jan25
Equity-to-Asset Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.80 0.77 0.72 0.52 0.31

Competitive Comparison of HeartSciences's Equity-to-Asset

For the Medical Devices subindustry, HeartSciences's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HeartSciences's Equity-to-Asset Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, HeartSciences's Equity-to-Asset distribution charts can be found below:

* The bar in red indicates where HeartSciences's Equity-to-Asset falls into.


;
;

HeartSciences Equity-to-Asset Calculation

Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.

Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.

HeartSciences's Equity to Asset Ratio for the fiscal year that ended in Apr. 2024 is calculated as

Equity to Asset (A: Apr. 2024 )=Total Stockholders Equity/Total Assets
=7.317/9.503
=0.77

HeartSciences's Equity to Asset Ratio for the quarter that ended in Jan. 2025 is calculated as

Equity to Asset (Q: Jan. 2025 )=Total Stockholders Equity/Total Assets
=1.787/5.704
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HeartSciences  (NAS:HSCS) Equity-to-Asset Explanation

Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.

For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.


HeartSciences Equity-to-Asset Related Terms

Thank you for viewing the detailed overview of HeartSciences's Equity-to-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.


HeartSciences Business Description

Traded in Other Exchanges
N/A
Address
550 Reserve Street, Suite 360, Southlake, TX, USA, 76092
HeartSciences Inc is an artificial intelligence (AI)-powered medical technology company focused on transforming ECGs/EKGs to save lives through earlier detection of heart disease. Its objective is to improve healthcare by making it a far more valuable cardiac screening tool, particularly in frontline or point-of-care clinical settings. It is developing a suite of AI-ECG diagnostic solutions for use in any healthcare care setting, either via MyoVista Insights cloud-platform using one of the millions of ECG devices currently in clinical use or via MyoVista wavECG Device.
Executives
David R. Wells director 2801 OCEAN PARK BLVD., SUITE 339, SANTA MONICA CA 90405
Bruce Bent director 750 BONHAM PARKWAY, LANTANA TX 76226
Mark T Hilz director, officer: See Remarks 3301 DAKOTA DRIVE, NORTHLAKE TX 76226
Patrick Kanouff director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Brian Szymczak director 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Danielle Watson officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092
Andrew Simpson director, officer: See Remarks 550 RESERVE STREET, SUITE 360, SOUTHLAKE TX 76092